COPD and Asthma Can Delay Lung Cancer Diagnosis by Masking Early Symptoms
Patients with chronic conditions like COPD and asthma are diagnosed with lung cancer significantly later than those without these conditions.
Patients with chronic conditions like COPD and asthma are diagnosed with lung cancer significantly later than those without these conditions.
The American Lung Association releases data that examines knowledge about lung cancer on World Lung Cancer Day.
Less than 20% of eligible individuals in the US are up-to-date with lung cancer screenings, with the lowest rates in uninsured and Southern populations.
A study examined the comparative effects of specific exercises on sleep quality in patients with advanced lung cancer, finding one method particularly effective.
Read MoreGenentech says the approval makes the drug the first ALK inhibitor for patients with ALK-positive, early-stage non-small cell lung cancer who have undergone surgery.Â
Read MoreResearchers from Weill Cornell Medicine have developed a model of histological transformation that details how lung adenocarcinomas can transform into a more aggressive small cell lung cancer.
Read MoreNew findings from Umeå University reveal a perplexing trend in Sweden: Declining smoking rates are not significantly impacting lung cancer cases, particularly among women.
Read MoreA study surveying patients who underwent robotic lung surgery found that many experience longer healing times than the commonly advised six-week recovery period.
Read MoreNew research may have revealed how lung cancer cells can persist in smoke. The mechanism could be related to how cancer cells develop resistance to pharmaceutical treatments as well.
Read MoreResearchers have built a compact robotic system that can autonomously steer a flexible needle around anatomical obstacles within the lungs of live animals.
Read MorePenn engineers have developed a new means of targeting the lungs with lipid nanoparticles—the miniscule capsules used by the Moderna and Pfizer-BioNTech COVID-19 vaccines to deliver mRNA—opening the door to novel treatments for pulmonary diseases like cystic fibrosis.Â
Read MoreUS Department of Labor safety investigators found a Selma, Ala, brick manufacturer exposed workers to silica crystalline respiratory hazards that have the potential to lead to lung cancer, chronic obstructive pulmonary disease, and kidney disease.Â
Read MoreThe designation is based on the preliminary safety and activity of NVL-520 in heavily pretreated patients with advanced ROS1-positive non-small cell lung cancer in the phase 1 portion of a phase 1/2 clinical trial.
Read MoreThe FDA approved osimertinib (Tagrisso) with platinum-based chemotherapy for certain patients with non-small cell lung cancer (NSCLC).
Read MoreFunding awarded to scientists at Camino Pharma, Sanford Burnham Prebys, and UC San Diego will expand the nonclinical studies to support a phase 2 clinical evaluation of SBP-9330.
Read More